 use suppress chronic ventricular arrhythmia sotalol uniqu beta-block drug signific class iii antiarrhythm activ efficaci safeti dose sotalol mg/day dose random double-blind multicent studi patient chronic ventricular prematur complex vpc frequenc equal sotalol vpc patient low high dose patient placebo sotalol vs placebo high vs low dose individu efficaci criterion equal vpc reduct low-dos high-dos sotalol placebo-tr patient sotalol vs placebo high vs low dose repetit beat placebo differ signific low-dos high-dos sotalol sotalol heart rate PR JT interv eject fraction proarrhythmia nonfat sotalol placebo patient nine therapi advers effect low dose high dose summari efficaci antiarrhythm drug vpc suppress dose less effect